Related Experiment Video
Updated: Jan 16, 2026
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Engineering Study on Targeted Therapy of Osteosarcoma Using Tripterine Loaded Polydopamine Mesoporous Microspheres
Molin Li1,2, Yufei Ma3, Hui Yao1
1Department of Pathology, Chongqing General Hospital, Chongqing University, Chongqing, 401147, People's Republic of China.
Purpose:
Osteosarcoma poses significant clinical challenges due to its high recurrence, metastatic potential, and poor prognosis. Celastrol (CLT), known for its antitumor, immunomodulatory, and osteogenic regulatory properties, has garnered substantial interest. Developing a targeted CLT delivery system is critical to enable precise drug release, integrate photothermal therapy, remodel the tumor microenvironment, and improve post-surgical treatment and repair in osteosarcoma.
Methods:
Using emulsion-induced interface assembly, we synthesized mesoporous polydopamine-polyethylene glycol (MPDA-PEG) nanospheres and loaded them with celastrol to fabricate the targeted system MPDA-PEG-CLT. We characterized the nanospheres' physicochemical properties and evaluated MPDA-PEG-CLT's efficacy in synergistic drug-photothermal therapy for osteosarcoma through in vitro and in vivo experiments.
Results:
MPDA-PEG-CLT achieved a drug loading capacity of ~14% and a photothermal conversion efficiency of 37.6% under 808 nm NIR irradiation, which enhanced celastrol release. The system induced osteosarcoma cell apoptosis, promoted bone marrow mesenchymal stem cell (BMSC) differentiation, and ameliorated the lesion microenvironment, resulting in efficient tumor ablation in mice.
Conclusion:
MPDA-PEG-CLT significantly enhances celastrol's targeted delivery efficiency, promotes mitochondrial apoptosis in osteosarcoma cells, synergizes with photothermal therapy to eradicate tumors, and improves the bone tissue microenvironment in lesions. This system offers a promising strategy for post-surgical osteosarcoma treatment and repair.
Insights
A novel mesoporous polydopamine-polyethylene glycol-celastrol (MPDA-PEG-CLT) nanosphere system effectively targets osteosarcoma. This system combines drug delivery and photothermal therapy for enhanced tumor ablation and bone repair.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Osteosarcoma presents significant challenges due to high recurrence and metastatic potential.
- Celastrol (CLT) exhibits antitumor and immunomodulatory properties, making it a candidate for osteosarcoma treatment.
- Targeted delivery systems are crucial for precise drug release and enhanced therapeutic outcomes in osteosarcoma.
Purpose of the Study:
- To develop a targeted celastrol (CLT) delivery system for osteosarcoma.
- To integrate drug delivery with photothermal therapy for synergistic effects.
- To improve post-surgical treatment and bone repair in osteosarcoma models.
Main Methods:
- Mesoporous polydopamine-polyethylene glycol (MPDA-PEG) nanospheres were synthesized via emulsion-induced interface assembly.
- Celastrol (CLT) was loaded into MPDA-PEG nanospheres to create the MPDA-PEG-CLT system.
- In vitro and in vivo experiments evaluated the efficacy of MPDA-PEG-CLT in synergistic drug-photothermal therapy for osteosarcoma.
Main Results:
- MPDA-PEG-CLT demonstrated a drug loading capacity of ~14% and 37.6% photothermal conversion efficiency under 808 nm NIR irradiation.
- The system induced osteosarcoma cell apoptosis and promoted bone marrow mesenchymal stem cell (BMSC) differentiation.
- Efficient tumor ablation was achieved in mice, with amelioration of the tumor microenvironment.
Conclusions:
- MPDA-PEG-CLT enhances targeted celastrol delivery and promotes mitochondrial apoptosis in osteosarcoma cells.
- The system synergizes with photothermal therapy for tumor eradication and improves the bone tissue microenvironment.
- This nanocarrier system shows promise for post-surgical osteosarcoma treatment and bone repair.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
